Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Schibli

Showing results (191-200 of 301) with videos related to

Pageof 31
Sort By:
Chemical Communications (Cambridge, England)|April 5, 2016
Novel chemoselective (18)F-radiolabeling of thiol-containing biomolecules under mild aqueous conditionsAristeidis Chiotellis, Filippo Sladojevich, Linjing Mu, et al.
Cancers|January 19, 2020
L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell PopulationNastassja Terraneo, Francis Jacob, Claudia Peitzsch, et al.
European Journal of Medicinal Chemistry|January 23, 2018
Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissueAchi Haider, Francesco Spinelli, Adrienne Müller Herde, et al.
Molecular Imaging and Biology|October 13, 2021
In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRIRuiqing Ni, Adrienne Müller Herde, Achi Haider, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 21, 2014
Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5)Selena Milicevic Sephton, Adrienne Müller Herde, Linjing Mu, et al.
Nuclear Medicine and Biology|November 13, 2016
Evaluation of the first <sup>44</sup>Sc-labeled Affibody molecule for imaging of HER2-expressing tumorsHadis Honarvar, Cristina Müller, Susan Cohrs, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5Selena Milicevic Sephton, Patrick Dennler, Dominique S Leutwiler, et al.
The International Journal of Cardiovascular Imaging|July 17, 2015
Ex vivo differential phase contrast and magnetic resonance imaging for characterization of human carotid atherosclerotic plaquesRomana Meletta, Nicole Borel, Paul Stolzmann, et al.
Journal of Neurochemistry|June 26, 2013
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptorLinjing Mu, Daniel Bieri, Roger Slavik, et al.
Bioconjugate Chemistry|December 5, 2008
Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivativeTobias L Ross, Michael Honer, Phoebe Y H Lam, et al.
Pageof 31

Showing results (191-200 of 301) with videos related to

Sort By:
Pageof 31
Chemical Communications (Cambridge, England)|April 5, 2016
Novel chemoselective (18)F-radiolabeling of thiol-containing biomolecules under mild aqueous conditionsAristeidis Chiotellis, Filippo Sladojevich, Linjing Mu, et al.
Cancers|January 19, 2020
L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell PopulationNastassja Terraneo, Francis Jacob, Claudia Peitzsch, et al.
European Journal of Medicinal Chemistry|January 23, 2018
Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissueAchi Haider, Francesco Spinelli, Adrienne Müller Herde, et al.
Molecular Imaging and Biology|October 13, 2021
In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRIRuiqing Ni, Adrienne Müller Herde, Achi Haider, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 21, 2014
Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5)Selena Milicevic Sephton, Adrienne Müller Herde, Linjing Mu, et al.
Nuclear Medicine and Biology|November 13, 2016
Evaluation of the first <sup>44</sup>Sc-labeled Affibody molecule for imaging of HER2-expressing tumorsHadis Honarvar, Cristina Müller, Susan Cohrs, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5Selena Milicevic Sephton, Patrick Dennler, Dominique S Leutwiler, et al.
The International Journal of Cardiovascular Imaging|July 17, 2015
Ex vivo differential phase contrast and magnetic resonance imaging for characterization of human carotid atherosclerotic plaquesRomana Meletta, Nicole Borel, Paul Stolzmann, et al.
Journal of Neurochemistry|June 26, 2013
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptorLinjing Mu, Daniel Bieri, Roger Slavik, et al.
Bioconjugate Chemistry|December 5, 2008
Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivativeTobias L Ross, Michael Honer, Phoebe Y H Lam, et al.
Pageof 31